P802: Impact of early use of immunomodulator on the outcomes of Crohn@E@s disease: A Systematic Review and Meta-AnalysisECCO'24Year: 2024
Authors: Yoo, J.H.(1)*;Yoon , J.(2);Jun , Y.K.(3);Lee , H.S.(4);ParkAssistant professor, J.J.(5);
(1)CHA Bundang Medical Center- CHA University School of Medicine, Gastroenterology, Seongnam, Korea- Republic Of;(2)Kangdong Sacred Heart Hospital, Internal Medicine, Seoul, Korea- Republic Of;(3)Seoul National University Bundang Hospital, Internal Medicine, Seoul, Korea- Republic Of;(4)Yonsei University College of Medicine, Biostatics Collaboration Unit, Seoul, Korea- Republic Of;(5)Severance Hospital- Yonsei University College of Medicine, Internal Medicine, Seoul, Korea- Republic Of;
P803: iGenoMed-MTT: A prospective multiomic study of response to molecularly targeted therapies in IBD.ECCO'24Year: 2024
Authors: Battat, R.(1)*;Boucher, G.(2);Thompson Legault, J.(2);Mercier, V.(2);Bitton, A.(3);Rioux, J.(2);
(1)University of Montreal, Gastroenterology and Hepatology, Montreal, Canada;(2)Montreal Heart Institute, Genetics, Montreal, Canada;(3)McGill University Health Centre, Gastroenterology, Montreal, Canada;
P804: Does Crohn@E@s disease extent and behavior have an impact on ustekinumab effectiveness? A real-world multicenter retrospective studyECCO'24Year: 2024
Authors: Samarentsis, N.(1);Kapizioni, C.(1)*;Georgakopoulou, N.(2);Michalopoulos, G.(2);Striki, A.(2);Karoumpalis, I.(2);Kartsoli, S.(3);Mellos, A.(3);Vrakas, S.(3);Vougadiotis, I.(3);Neonaki, A.(4);Karatzas, P.(4);Tsiamperas, N.(5);Kourikou, A.(5);Siakavellas, S.(5);Polymeros, D.(1);Manolakopoulos, S.(5);Papatheodoridis, G.(4);Triantafyllou, K.(1);
(1)Attikon University Hospital, Hepatogastroenterology Unit- 2nd Academic Department of Internal Medicine, Athens, Greece;(2)General Hospital @D@G.Gennimatas@D@, Department of Gastroenterology, Athens, Greece;(3)Tzaneio General Hospital, Department of Gastroenterology, Piraeus, Greece;(4)Laiko General Hospital, Department of Gastroenterology, Athens, Greece;(5)Hippocration General Hospital, Hepatogastroenterology Unit- 2nd Academic Department of Internal Medicine, Athens, Greece;
P805: The persistence of subcutaneous infliximab is equivalent to intravenous form in patients with inflammatory bowel diseases.ECCO'24Year: 2024
Authors: Bothorel, L.(1);Laharie, D.(1);Poullenot, F.(1);Gohier, E.(1);Chevrier, C.(1);Berger, A.(1);Zerbib, F.(1);Riviere, P.(1)*;
(1)Bordeaux University Hospitals, Gastroenterology department, Bordeaux, France;
P806: Development of a clinical model to predict secondary non-response of anti-TNFα treatment on Crohn@E@s diseaseECCO'24Year: 2024
Authors: Xiang, L.(1)*;Xiaomei, S.(1);Yan, L.(1);Wei, T.(1);Hong, G.(1);
(1)Chongqing General Hospital, Department of Gastroenterology, Chongqing, China;
P807: HLA type impact on immunization and efficacy of ustekinumab in IBD patients: a multicenter studyECCO'24Year: 2024
Authors: Delmeule, A.(1)*;Dubois, V.(2);gay, C.(1);Roblin, X.(3);Paul, S.(3);Nancey, S.(1);Boschetti, G.(1);
(1)CHU de Lyon, rhone, Lyon, France;(2)EFS, Rhone, Décines, France;(3)CHU de saint etienne, loire, saint etienne, France;
P808: Use of intestinal ultrasound influences the proportion of suboptimally controlled patients: IBD Podcast Study resultsECCO'24Year: 2024
Authors: Dignass, A.(1)*;D@E@Amico, F.(2);Gomollón, F.(3);Bamias, G.(4);Heatta-Speicher, T.(5);Michelena, N.(6);Leitner, C.(7);Hammer, L.(8);Magro, F.(9);
(1)Agaplesion Markus Hospital, Department of Medicine I, Frankfurt am Main, Germany;(2)IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Gastroenterology and Endoscopy, Milan, Italy;(3)Universitario Lozano Blesa, Hospital Clínico, Zaragoza, Spain;(4)Sotiria Hospital- National & Kapodistrian University of Athens, GI-Unit- 3rd Academic Dpt. Of Internal Medicine, Athens, Greece;(5)AbbVie AS, Immunology, Oslo, Norway;(6)AbbVie Spain- SLU, Immunology, Madrid, Spain;(7)AbbVie Switzerland, Immunology, Cham, Switzerland;(8)AbbVie Deutschland GmbH & Co. KG, Immunology, Wiesbaden, Germany;(9)Faculdade de Medicina da Universidade do Porto, CINTESIS@RISE Departament, Porto, Portugal;on behalf of the IBD-Podcast study group
P809: VARIETY BEACH: Real-world treatment patterns for vedolizumab intravenous and subcutaneous maintenance dosing observed over 1 year in studies from Belgium, Austria and Switzerland.ECCO'24Year: 2024
Authors: Novacek, G.(1)*;Hrúz, P.(2);Högenauer, C.(3);Louis, E.(4);Vavricka, S.R.(5,6);Moschen, A.R.(7);Biedermann, L.(5);Mächler, C.(8);Stemberger, B.(9);Van Gassen, G.(10);Baert, F.(11);
(1)Medical University of Vienna, Department of Internal Medicine III, Vienna, Austria;(2)Clarunis Universitäres Bauchzentrum, Department of Gastroenterology and Hepatology, Basel, Switzerland;(3)Medical University Graz, Department of Gastroenterology and Hepatology, Graz, Austria;(4)University Hospital CHU of Liège, Department of Gastroenterology, Liège, Belgium;(5)University Hospital Zürich, Department of Gastroenterology and Hepatology, Zürich, Switzerland;(6)Center for Gastroenterology and Hepatology, Department of Gastroenterology and Hepatology, Zürich, Switzerland;(7)Johannes Kepler University Faculty of Medicine, Department of Internal Medicine 2, Linz, Austria;(8)Takeda Pharma AG, Gastroenterology, Glattpark, Switzerland;(9)Takeda Ges.m.b.H, Gastroenterology, Vienna, Austria;(10)Takeda Belgium NV, Gastroenterology, Brussels, Belgium;(11)AZ Delta, Department of Gastroenterology, Roeselare, Belgium;
P810: Fecal microbiota transplantation in Ulcerative rectocolitisECCO'24Year: 2024
Authors: Ferreira, F.(1)*;Sousa, M.(2);Melado , M.(2);Pacheco, M.(3);Trindade, L.(3);Lorentz, F.(3);Carmo, L.(3);Clara, A.(3);
(1)Hospital da Santa Casa de Micericórdia de Vitória, Gastroenterology, Vitoria, Brazil;(2)Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória, Medicine, Vitória, Brazil;(3)Hospital da Santa Casa de Misericórdia de Vitória, Gastroenterology, Vitória, Brazil;
P811: Age as a Predictor of Serum Tumor Necrosis Factor Antagonist Drug and Anti-drug Antibody Concentrations in Inflammatory Bowel Disease; A Nationwide Retrospective StudyECCO'24Year: 2024
Authors: Shehab, M.(1)*;Alrashed, F.(2);Alfadhli, A.(1);
(1)Mubarak Al-Kabeer Hospital, Internal medicine, Kuwait, Kuwait;(2)Kuwait University, Pharmacy Practice, Kuwait, Kuwait;
P812: Whole Food and Antioxidants Consumption Linked to Lower Risk of Inflammatory Bowel Disease in TaiwanECCO'24Year: 2024
Authors: Meng, M.J.(1)*;Huang, J.(2);Le, P.H.(3);Pan, Y.B.(4);Chiu, C.T.(1);Lin, Y.T.(1);
(1)Chang Gung Memorial Hospital- Linkou Branch- Taoyuan- Taiwan, Department of Gastroenterology and Hepatology, Taoyuan, Taiwan;(2)Chang Gung Memorial Hospital Linkuo Branch- Taoyuan City- Taiwan, Department of Clinical Nutrition Therapy, Taoyuan, Taiwan;(3)Chang Gung Memorial Hospital- Linkou Branch- Taoyuan- Taiwan, Department of Gastroenterology and Hepatology, New Taipei City, Taiwan;(4)Chang Gung Memorial Hospital- Linkou Branch- Taoyuan- Taiwan, Biostatistical Section- Clinical Trial Center, Taoyuan, Taiwan;
P813: A questionnaire-based study on fatigue and associated factors in Inflammatory Bowel DiseaseECCO'24Year: 2024
Authors: Jeong, N.(1)*;Lee, H.H.(1);
(1)Yeouido ST. Mary’s Hospital, Department of Internal Medicine, Seoul, Korea- Republic Of;
P814: Empowering IBD communities worldwide: The global impact of www.ibd-eii.com in disseminating evidence-based information and educational supportECCO'24Year: 2024
Authors: Gros, B.(1,2)*;
(1)Western General Hospital, Edinburgh IBD Unit, Edinburgh, United Kingdom;(2)Reina Sofía University Hospital, Department of Gastroenterology and Hepatology, Cordoba, Spain;
P815: Infliximab drug monitoring: proactive or reactive: a North West England NHS 3 trust retrospective studyECCO'24Year: 2024
Authors: Campbell, R.(1)*;Nelson, E.(2);Everall, J.(3);Ash, N.(3);Mountford, J.(4);Davies, J.(5);
(1)Stepping Hill Hospital, Gastroenterology, Stockport, United Kingdom;(2)East Cheshire NHS Trust, Gastroenterology, Cheshire, United Kingdom;(3)Warrington and Halton teaching hospitals NHS Foundation Trust, Gastroenterology, Warrington, United Kingdom;(4)East Cheshire NHS Trust, Gastroenterology, Macclesfield, United Kingdom;(5)Stockport NHS Foundation Trust, Gastroenterology, Cheshire, United Kingdom;
P816: Baseline disease severity of patients with Ulcerative Colitis influences rapid symptom relief under filgotinib treatment: post hoc analysis of the phase 2b/3 SELECTION studyECCO'24Year: 2024
Authors: Saruta, M.(1)*;Danese, S.(2,3);Takatori, Y.(4);Kaise, T.(4);Rudolph, C.(5);Ferrante, M.(6);Hibi, T.(7);
(1)The Jikei University School of Medicine, Division of Gastroenterology and Hepatology- Department of Internal Medicine, Tokyo, Japan;(2)IRCCS Ospedale San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(3)Vita-Salute San Raffaele University, Medicine and Surgery Department, Milan, Italy;(4)Gilead Sciences, K.k., Tokyo, Japan;(5)Galapagos, Nv, Mechelen, Belgium;(6)University Hospitals Leuven- KU Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(7)Kitasato University Kitasato Institute Hospital, Center for Advanced IBD Research and Treatment, Tokyo, Japan;
P817: Incidence and risk factors of infection in patients with inflammatory bowel disease: longitudinal prospective INFEII registry of GETECCUECCO'24Year: 2024
Authors: Zabana, Y.(1,2)*;Rodríguez-Lago, I.(3);Sicilia, B.(4);de Francisco, R.(5);Piqueras, M.(6);de Castro, L.(7);Chaparro, M.(2,8);Gomollón, F.(2,9);Domènech, E.(2,10);Llaó, J.(11);Márquez-Mosquera, L.(12);Lucendo, A.(2,13);García-Bosch, O.(14);Calvet, X.(2,15);Gordillo, J.(16);Busquets, D.(17);Morales, V.(18);Rivero, M.(19);Guardiola, J.(20);Navarro, P.(21);Iglesias, E.(22);Iborra, M.(23);Ferreiro-Iglesias, R.(24);Mesonero, F.(25);Sesé, E.(26);Vicente, R.(27);Pajares, R.(28);Algaba, A.(29);Benítez, O.(1);Aceituno, M.(1,2);Rodríguez-Pescador, A.(3);Arias-García, L.(4);Riestra, S.(5);Mena, R.(6);Sanromán, L.(7);P. Gisbert, J.(2,8);Arroyo, M.T.(9);Mañosa, M.(2,10);Sáinz, E.(11);Esteve, M.(1,2);
(1)Hospital Universitari Mútua Terrassa, Gastroenterology Department, Terrassa, Spain;(2)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, CIBERehd, Madrid, Spain;(3)Hospital de Galdakao, Gastroenterology Department, Galdakao, Spain;(4)Hospital Universitario de Burgos, Gastroenterology Department, Burgos, Spain;(5)Hospital Central de Asturias, Gastroenterology Department, Oviedo, Spain;(6)Consorci Sanitari de Terrassa, Gastroenterology Department, Terrassa, Spain;(7)Hospital Álvaro Cunqueiro-Complejo Hospitalario Universitario de Vigo, Gastroenterology Department, Vigo, Spain;(8)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-Princesa and Universidad Autónoma de Madrid UAM, Gastroenterology Department, Madrid, Spain;(9)Hospital Clínico Lozano Blesa and IIS Aragón, Gastroenterology Department, Zaragoza, Spain;(10)Hospital Universitari Germans Trias i Pujol, Gastroenterology Department, Badalona, Spain;(11)Hospital Sant Joan de Déu Althaia, Gastroenterology Department, Manresa, Spain;(12)Servei de Digestiu-Hospital del Mar and Hospital del Mar Research Institute IMIM Barcelona, Gastroenterology Department, Barcelona, Spain;(13)Hospital General de Tomelloso and Instituto de Investigación Sanitaria de Castilla-La Mancha IDISCAM, Gastroenterology Department, Tomelloso, Spain;(14)Hospital Moisés Broggi, Gastroenterology Department, Sant Joan Despí, Spain;(15)Hospital Universitari Parc Taulí Sabadell i Departament de Medicina- Facultat de Medicina- Universitat Autònoma de Barcelona, Gastroenterology Department, Sabadell, Spain;(16)Hospital Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(17)Hospital Universitari Dr. Josep Trueta, Gastroenterology Department, Girona, Spain;(18)Hospital General de Granollers, Gastroenterology Department, Granollers, Spain;(19)Hospital Marqués de Valdecilla- IDIVAL, Gastroenterology Department, Santander, Spain;(20)Hospital Universitari Bellvitge- IDIBELL and Universitat de Barcelona, Gastroenterology Department, L@E@Hospitalet de Llobregat, Spain;(21)Hospital Clínico de Valencia, Gastroenterology Department, Valencia, Spain;(22)Hospital Reina Sofía de Córdoba, Gastroenterology Department, Córdoba, Spain;(23)Hospital Universitario La Fe, Gastroenterology Department, Valencia, Spain;(24)Hospital Clínico Universitario Santiago and Fundación Instituto de Investigación Sanitaria de Santiago de Compostela FIDIS, Gastroenterology Department, Santiago de Compostela, Spain;(25)Hospital Universitario Ramón y Cajal, Gastroenterology Department, Madrid, Spain;(26)Hospital Arnau de Vilanova, Gastroenterology Department, Lleida, Spain;(27)Hospital Universitario Miguel Servet, Gastroenterology Department, Zaragoza, Spain;(28)Hospital Infanta Sofía, Gastroenterology Department, Madrid, Spain;(29)Hospital Universitario de Fuenlabrada- Instituto de Investigación de La Paz IdiPAZ, Gastroenterology Department, Fuenlabrada, Spain;GETECCU-INFEII group
P818: Imaging-based preoperative body composition is associated with the risk of postoperative complications and postoperative endoscopic recurrence in patients with Crohn’s diseaseECCO'24Year: 2024
Authors: Bak, M.(1)*;Demers, K.(2,3,4);van Ruler, O.(5,6);Pierik, M.J.(3,4);van der Bilt, J.D.W.(7,8);Romberg-Camps, M.(9);Dijkstra, G.(10);Duijvestein, M.(11);van der Marel, S.(12);Maljaars, P.W.J.(13);Buskens, C.J.(8);Bakers, F.C.H.(14);van Dijk, D.P.J.(2,3);Brecheisen, R.(3);Bongers, B.C.(3);van Rossum, E.F.C.(15,16);de Witte, D.(17);Jansen, S.V.(18);Jharap, B.J.H.(19);Horjus, C.S.(20);van Schaik, F.D.M.(21);West, R.L.(22);de Boer, N.K.H.(23);van der Woude, C.J.(1);Stassen, L.P.S.(2,3);de Vries, A.C.(1);
(1)Erasmus University Medical Center Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)Maastricht University Medical Center+, Department of Surgery, Maastricht, The Netherlands;(3)Maastricht University, Research Institute for Nutrition and Translational Research in Metabolism NUTRIM, Maastricht, The Netherlands;(4)Maastricht University Medical Center+, Department of Gastroenterology and Hepatology, Maastricht, The Netherlands;(5)IJsselland Hospital, Department of Surgery, Capelle aan den IJssel, The Netherlands;(6)Erasmus University Medical Center Rotterdam, Department of Surgery, Rotterdam, The Netherlands;(7)Flevoziekenhuis, Department of Surgery, Almere, The Netherlands;(8)Amsterdam University Medical Center, Department of Surgery, Amsterdam, The Netherlands;(9)Zuyderland Medical Centre, Department of Gastroenterology-Geriatrics-Internal and Intensive Care Medicine Co-MIK, Heerlen-Sittard-Geleen, The Netherlands;(10)University Medical Center Groningen- University of Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands;(11)Radboud University Medical Center, Department of Gastroenterology and Hepatology, Nijmegen, The Netherlands;(12)Haaglanden Medical Center, Department of Gastroenterology and Hepatology, The Hague, The Netherlands;(13)Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, The Netherlands;(14)Maastricht University Medical Center+, Department of Radiology and Nuclear Medicine, Maastricht, The Netherlands;(15)Erasmus University Medical Center Rotterdam, Department of Internal Medicine- Division of Endocrinology, Rotterdam, The Netherlands;(16)Erasmus University Medical Center Rotterdam, Obesity Center CGG, Rotterdam, The Netherlands;(17)Erasmus University Medical Center Rotterdam, Department of Radiology, Rotterdam, The Netherlands;(18)Reinier de Graaf Groep, Department of Gastroenterology and Hepatology, Delft, The Netherlands;(19)Meander Medical Center, Department of Gastroenterology and Hepatology, Amersfoort, The Netherlands;(20)Rijnstate Hospital, Department of Gastroenterology and Hepatology, Arnhem, The Netherlands;(21)University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht, The Netherlands;(22)Franciscus Gasthuis & Vlietland, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(23)Amsterdam University Medical Centers- Vrije Universiteit Amsterdam- AGEM Research Institute, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;on behalf of the RAP-CD study group and on behalf of the Dutch Initiative on Crohn and Colitis (ICC) & Dutch Initiative on Crohn and Colitis – Surgery (ICC-S)
P819: Postoperative prophylaxis prevents surgical and severe endoscopic recurrence after primary ileocecal resection in CD patientsECCO'24Year: 2024
Authors: ten Bokkel Huinink, S.(1);Bak, M.(1)*;Beelen, E.(1);Erler, N.(2);Hoentjen, F.(3);Bodelier, A.(4);Dijkstra, G.(5);Romberg-Camps, M.(6);de Boer, N.(7);Stassen, L.(8);van der Meulen-de Jong, A.(9);West, R.(10);van der Woude , C.J.(1);van Ruler, O.(11);de Vries, A.(1);
(1)Erasmus University Medical Center Rotterdam, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(2)Erasmus University Medical Center Rotterdam, Department of Biostatistics, Rotterdam, The Netherlands;(3)University of Alberta, Division of Gastroenterology and Hepatology, Alberta, Canada;(4)Amphia Hospital, Department of Gastroenterology and Hepatology, Breda, The Netherlands;(5)University Medical Center Groningen, De, Groningen, The Netherlands;(6)Zuyderland Medical Center, Department of Gastroenterology and Hepatology, Heerlen-Sittard-Geleen, The Netherlands;(7)Amsterdam University Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(8)Maastricht University Medical Center, Department of Surgery, Maastricht, The Netherlands;(9)Leiden University Medical Center, Department of Gastroenterology and Hepatology, Leiden, The Netherlands;(10)Franscisus Gasthuis & Vlietland, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands;(11)IJsselland Hospital, Department of Surgery, Capelle aan den IJssel, The Netherlands;on behalf of the Dutch Initiative on Crohn and Colitis (ICC)
P820: Targeting MM-SES-CD < 22.5 for endoscopic improvement is feasible in a clinical trial of Crohn’s disease: A post-hoc analysis of SEAVUEECCO'24Year: 2024
Authors: Narula, N.(1)*;Wong, E.C.(1);Dulai, P.S.(2);Marshall, J.K.(1);Jairath, V.(3);Ungaro, R.C.(4);Colombel, J.F.(4);Reinisch, W.(5);
(1)McMaster University, Gastroenterology, Hamilton, Canada;(2)Northwestern University, Gastroenterology, Chicago, United States;(3)Western University, Gastroenterology, London, Canada;(4)Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States;(5)Medical University of Vienna, Gastroenterology, Vienna, Austria;
P821: Multi-site analysis of upadacitinib effectiveness in Crohn@E@s Disease patients: A UK perspectiveECCO'24Year: 2024
Authors: Radia, C.(1)*;Danso, Y.(2);Kok, K.(2);Samaan, M.(3);Kent, A.J.(1);Pavlidis, P.(1);Patel, K.(4);Harrow, P.(5);Yeung, K.(6);Hussain, M.A.(7);Dong, C.(8);Morris, T.(2);Patel, C.(3);Cummings, J.F.(9);Hale, M.(10);Pillay, L.(11);Walsh, A.(12);Sebastian, S.(13);Trodden-Mittnacht, H.(14);Davis, E.(12);Yeo, J.H.(15);Campbell, R.(16);Mehta, S.(17);Sethi-Arora, K.(18);Fraser, A.(19);George, B.(20);Harvey, P.(21);Sawan, N.J.(22);Hicks, L.(23);Allah-Ditta, M.(24);Johnston, E.(25);Dhar, A.(26);Al-zarrad, D.(27);Kumar, R.(28);Young, D.(9);Butler, K.(10);Raine, T.(11);Rice, J.(13);Hewitt, A.(14);Selinger, C.(14);
(1)King@E@s College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom;(2)Barts Health NHS Trust, Gastroenterology, London, United Kingdom;(3)Guy@E@s and St Thomas@E@ NHS Foundation Trust, Gastroenterology, London, United Kingdom;(4)St George@E@s University Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(5)University College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(6)St Mark@E@s Hospital, Gastroenterology, London, United Kingdom;(7)University Hospital Birmingham NHS Foundation Trust, Gastroenterology, Birmingham, United Kingdom;(8)Royal Victoria Infirmary- Newcastle-Upon-Tyne Hospitals, Gastroenterology, Newcastle, United Kingdom;(9)University Hospital Southampton, Gastroenterology, Southampton, United Kingdom;(10)Sheffield Teaching Hospitals NHS Foundation Trust, Gastroenterology, Sheffield, United Kingdom;(11)Cambridge University Hospitals NHS Foundation Trust, Gastroenterology, Cambridge, United Kingdom;(12)Oxford University Hospitals, Gastroenterology, Oxford, United Kingdom;(13)Hull University Teaching Hospitals, Gastroenterology, Hull, United Kingdom;(14)Leeds Teaching Hospitals NHS Trust., Gastroenterology, Leeds, United Kingdom;(15)Univesity College London Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(16)Queen Elizabeth University Hospital, Gastroenterology, Glasgow, United Kingdom;(17)St George’s University Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(18)Northern Care Alliance NHS Foundation Trust, Gastroenterology, Manchester, United Kingdom;(19)Bristol Royal Infirmary, Gastroenterology, Bristol, United Kingdom;(20)Torbay and South Devon NHS Foundation Trust, Gastroenterology, Torquay, United Kingdom;(21)The Royal Wolverhampton NHS Trust, Gastroenterology, Wolverhampton, United Kingdom;(22)Queen Elizabeth Hospital, Gastroenterology, London, United Kingdom;(23)Imperial College Healthcare NHS Trust, Gastroenterology, London, United Kingdom;(24)Calderdale and Huddersfield Foundation Trust, Gastroenterology, Huddersfiled, United Kingdom;(25)Chelsea and Westminster Hospitals NHS Foundation Trust, Gastroenterology, London, United Kingdom;(26)County Durham & Darlington NHS Foundation Trust, Gastroenterology, Durham, United Kingdom;(27)St Marks Hospital, Gastroenterology, London, United Kingdom;(28)University Hospitals Birmingham NHS Foundation Trust, Gastroenterology, Birmingham, United Kingdom;